Development History

2024

2023

2022

2021

2020

2019

2018

2017

2016

2024.3

DHCtech has made a significant release with its multi-modal clinical research integrated machine, which combines hardware and software into a unified platform for both clinical applications and scientific research.
2024.3

DHCtech has made a significant announcement with the release of its large model, independently developing foundational models across four modalities: text, imaging, pathology, and precision. This initiative aims to create a multi-modal intelligent entity specifically for the medical vertical domain.

2023.12

DHCtech has been approved for one key project of the National Natural Science Foundation and three major research projects under the "14th Five-Year Plan" national key research and development program. It leads one subproject and participates in six subprojects, covering three major disease
2023.9

The Nanfang Hospital Project, the first hospital-wide multi-modal big data integration research platform in China undertaken by DHCtech, was officially put into use
2023.8

The China Children's Immune Disease Research Network Platform built by DHCtech was successfully launched
2023.8

DHCtech, as the unit in charge of the project, was approved for the integration project of biology and information technology of the National Development and Reform Commission, with a total investment of more than 300 million RMB
2023.6

DHCtech won the title of Leading Innovative Digital Medical Enterprise in China
2023.5

DHCtech won the Excellent Enterprise of Guangzhou Forum on Medical Informatization
2023.1

DHCtech won the Best Contribution Award of the first tumor artificial intelligence committee of China Anti-Cancer Association

2022.12

DHCtech won the TOP10 of 2022 China Medical Big Data Enterprise
2022.12

DHCtech won the Best Innovative Application Award of Precision Medical Big Data in 2022
2022.11

DHCtech won 8 national key R&D projects in the 14th Five-Year Plan
2022.9

DHCtech won the Best Innovative Application Award for Smart Diagnosis and Treatment
2022.7

DHCtech won the title of Medical Big Data Unicorn Enterprise and Medical Artificial Intelligence Leading Enterprise in 2021

2021.12

DHCtech was awarded the 2021 Medical Big Data Unicorn Enterprise and Medical Artificial Intelligence Leader
2021.10

DHCtech builds a multi-center prostate cancer single-case big data platform
2021.7

DHCtech won the bid for an important smart medical and scientific research project in the northwest region, constructing a project to improve the diagnosis and treatment capacity of Shaanxi Cancer Hospital for difficult diseases, and building a scientific research platform for tumors in Shaanxi Prov
2021.6

DHCtech Healthcare was awarded CMMI Level 5 certification, marking a new level of strength in software development and project management
2021.4

DHCtech participated in the National Key Research and Development Program for Active Health and Scientific and Technological Response to Ageing, which was launched
2021.4

DHCtech won the bid for the Artificial Intelligence Imaging Intelligent Assisted Diagnosis and Decision-making Platform of Nanfang Hospital

2020.10

At the 83rd China International Medical Equipment Fair (CMEF), DHCtech and Philips jointly launched " ShineFly 3.0"
2020.2

The company completed Series A+ financing of RMB 2 billion, with strategic investments from SK Group, Tencent, Philips and others
2020.2

Entrusted by the National Health Commission, the company participated in and completed the national clinical data intelligence processing project for patients with new coronary pneumonia

2019.10

DHCtech won the first place in the 2019 Artificial Intelligence Assisted Target Area Sketching Competition scored by the experts of the GTV project for lung cancer and the second place overall at the 16th National Conference on Radiation Oncology Therapy of the Chinese Medical Association in 2019
2019.10

DHCtech won the bid for the project to improve the diagnosis and treatment capacity of difficult diseases in Nanfang Hospital of Southern Medical University
2019.4

DHCtech joined the Kidney Disease Professional Committee of China Health Information and Health Care Big Data Society, participating in the project led by Nanfang Hospital. Hou Fanfan academician-led research on the medical big data platform for nephrology, exclusively providing the core technology<
2019.3

A strategic agreement between DHCtech and IQVIA (US headquarters), a world-renowned human life data science company, jointly promoting the development of real-world research in China

2018.12

DHCtech builds the China Cardiovascular Consortium's national cardiovascular big data platform
2018.11

AMIA2018 China-US Joint Center for Medical Information and Big Data Science established
2018.11

DHCtech was listed in Deloitte 2018 China's Stars of Tomorrow
2018.11

DHCtech was selected as an innovative enterprise of the year in 2018 China's large health industry
2018.10

China Rare Disease Alliance was established in Beijing, and DHCtech was invited to be the first member of the Alliance
2018.8

DHCtech acquired Yihao, Herbots and Weishuo, and set up subsidiaries in the US and Singapore to start its global layout
2018.7

DHCtech completed Series A financing of nearly RMB 1 billion, introducing capitalists such as Guoxin Fund and Sequoia Capital
2018.6

DHCtech signed a cooperation agreement with the National Cancer Centre and Public Health England, absorbing the experience of building authoritative tumor data platforms from abroad and making every effort to build a big data platform for tumors in China
2018.2

DHCtech signed a strategic cooperation agreement with UK company Kangjiannike

2016.12

DHCtech undertakes the construction of national tumor data centre and tumor data platform project
2016.11

DHCtech and Philips, a global medical giant company, engaged in comprehensive and in-depth cooperation in the fields of tumor treatment, medical image processing, breast cancer screening, cardiovascular and cerebrovascular disease treatment, etc.
2016.10

DHCtech started cooperation with the international top Harvard-MIT Broad Institute and Bio-X researchers from Shanghai Jiaotong University on precision medical big data research
2016.9

Digital Health China Technologies Co., Ltd. was formally established